List of Prominent Players in the GLP-1 Market: AstraZeneca Biolingus Boehringer Ingelheim D&D Pharmatech Eli Lilly Gmax Biopharm Hanmi Pharmaceutical Innogen Novo Nordisk PegBio Pfizer QL Biopharma Roche Sanofi Sciwind Biosciences Tonghua Dongbao Pharmaceutical Viking Therapeutics Vivani vTv Therapeutic Expert Knowledge, Just a Click Away: Market Dynamics Drivers: The global surge in type 2 diabetes and obesity is a primary catalyst for the growth of the GLP-1 receptor agonist market
Lilly saw unprecedented weight loss
Ipamorelin is a growth hormone-releasing peptide that some people claim helps regulate metabolism and improve muscle tone, but theres little evidence to back up those claims, and the substance is not FDA approved for safe use by humans
Mucinex is often used to relieve symptoms of colds, flu, and respiratory infections
In addition, psychological problems such as depression, mood swings and personality changes are seen in some patients[11]
Angela Fitch, chief medical officer of Knownwell, a primary care and obesity medicine provider, and past president of the Obesity Medicine Association